Evelina London Children's Hospital is a specialist NHS hospital in London. It is administratively a part of Guy's and St Thomas' NHS Foundation Trust and provides teaching hospital facilities for London South Bank University and King's College London School of Medicine.

There are 140 beds in Evelina Childrens Hospital.

During the past decade, Evelina Childrens Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 8 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 5 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evelina Childrens Hospital" #1 sponsor was "BioMarin Pharmaceutical" with 8 trials, followed by "Kyowa Kirin Pharmaceutical Development Ltd" with 3 trials sponsored, "PENTA Foundation" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "ApoPharma" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evelina Childrens Hospital" #1 collaborator was "ANRS, Emerging Infectious Diseases" with 2 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 2 trials as a collaborator, "Immune Tolerance Network (ITN)" with 2 trials as a collaborator, "Imperial College London" with 2 trials as a collaborator and "Medical Research Council" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Evelina Childrens Hospital" are "Achondroplasia" (9 trials), "Food Allergy" (3 trials), "Sickle Cell Disease" (3 trials), "EPP" (2 trials) and "Egg Allergy" (2 trials). Many other conditions were trialed in "Evelina Childrens Hospital" in a lesser frequency.

Most popular intervention types in "Evelina Childrens Hospital" are "Drug" (26 trials), "Other" (8 trials), "Biological" (3 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "BMN 111" (5 trials), "Deferiprone" (2 trials), "Erenumab Dose 1" (2 trials) and "Erenumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Evelina Childrens Hospital" are 37 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Evelina Childrens Hospital". 1 are not yet recruiting, 7 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Evelina Childrens Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Evelina Childrens Hospital, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".